Response to a recently published systematic review on intranasal esketamine for major depressive disorder.

A recently published meta-analysis on the use of intranasal esketamine for the treatment of major depressive disorder included a mistake in the data analysis. This letter explains the error and offers an alternative analysis. Fortunately in this case the results are little effected.